Article Versions Notes

Rinaldi F, Hanieh PN, Sennato S, De Santis F, Forte J, Fraziano M, Casciardi S, Marianecci C, Bordi F, Carafa M. Rifampicin–Liposomes for Mycobacterium abscessus Infection Treatment: Intracellular Uptake and Antibacterial Activity Evaluation. Pharmaceutics. 2021; 13(7):1070. https://doi.org/10.3390/pharmaceutics13071070

Rinaldi, Federica, Patrizia Nadia Hanieh, Simona Sennato, Federica De Santis, Jacopo Forte, Maurizio Fraziano, Stefano Casciardi, Carlotta Marianecci, Federico Bordi, and Maria Carafa. 2021. "Rifampicin–Liposomes for Mycobacterium abscessus Infection Treatment: Intracellular Uptake and Antibacterial Activity Evaluation" Pharmaceutics 13, no. 7: 1070. https://doi.org/10.3390/pharmaceutics13071070

Rinaldi, F., Hanieh, P. N., Sennato, S., De Santis, F., Forte, J., Fraziano, M., Casciardi, S., Marianecci, C., Bordi, F., & Carafa, M. (2021). Rifampicin–Liposomes for Mycobacterium abscessus Infection Treatment: Intracellular Uptake and Antibacterial Activity Evaluation. Pharmaceutics, 13(7), 1070. https://doi.org/10.3390/pharmaceutics13071070